Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone Dosing in Sepsis-Associated Atrial Fibrillation
NCT02668432Phase 4Terminated
- Sponsor
- UT Health San Antonio
- Start
- May 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amiodarone in atrial fibrillation (AF), sponsored by UT Health San Antonio. Started May 2016; status: terminated.
02
Drugs
amiodarone
03
Conditions
atrial fibrillation (AF)
Beyond the preview
Go deeper on NCT02668432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02668432.